3rd party tested ghk cu GHK-CU – Research Peptide GHK-Cu Face Serum | 1200MG

Quick Comparison Molecular class: AOD-9604 is a synthetic HGH fragment (16 amino acids)

Kandhaya-Pillai, R

Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.25 + 0.5 mg (variant 5 + 5 mg pen = 15 clicks / variant 5 + 10 mg pen = 10 clicks) Duration: 8 12 weeks Frequency: 1 daily Cycle Interval: 4-week rest Goal / Description: Baseline GH and IGF-1 enhancement in research models Performance Study Protocol Dose: 0.5 + 1.0 mg (variant 5 + 5 mg pen = 30 clicks / variant 5 + 10 mg pen = 20 clicks) Duration: 8 12 weeks Frequency: 1 daily (evening) Cycle Interval: 8-week rest Goal / Description: Designed for muscle recovery and metabolic modulation experiments Every Other Day Protocol Dose: 0.5 + 0.5 mg (variant 5 + 5 mg pen = 20 clicks / variant 5 + 10 mg pen = 13 clicks) Duration: 8 12 weeks Frequency: Every Other Day Cycle Interval: 4-week rest Goal / Description: Pulsatile GH release pattern

Ideal Candidate Profiles Adults with confirmed GH deficiency by stimulation testing Patients experiencing age-related GH decline Individuals with mild to moderate metabolic syndrome Contraindications and Precautions Active cancer or history of pituitary tumors Untreated thyroid disorders Pregnancy or breastfeeding Severe kidney or liver impairment Disclose all medical history and medications before starting sermorelin therapy

Pickart and Thaler isolated it from human serum in 1973 and characterized it as a tripeptide that prolongs survival of normal liver cells and stimulates growth in neoplastic liver tissue 17